Lee Jong Hyuk, Choi Eun Jung, Han Seok Cheol, Chung Hee Sup, Kwon Mi Jung, Jayaram Prathap, Lee Wonjae, Lee Michael Y
Department of Physical Medicine and Rehabilitation, Veterans Health Service Medical Center, Seoul, Korea.
Department of Rehabilitation Medicine, Seongnam Citizens Medical Center, Seongnam, Korea.
Ultrasonography. 2021 Oct;40(4):555-564. doi: 10.14366/usg.20199. Epub 2021 Feb 22.
The purpose of this study was to compare the efficacy of low-dose steroid, highdose steroid, and low-dose steroid combined with hyaluronidase with respect to intra-articular injection therapy for adhesive capsulitis (AC) of the shoulder.
Thirty patients with primary AC in the initial stage were randomly assigned into three groups to receive ultrasound-guided intra-articular injections with 20 mg of triamcinolone acetonide (group A, n=10), 40 mg of triamcinolone acetonide (group B, n=10) and 20 mg of triamcinolone acetonide combined with hyaluronidase (group C, n=10). The outcome measures included a visual analogue scale (VAS), the Shoulder Disability Questionnaire (SDQ), abduction and external rotation range of motion, and intra-sheath fluid (ISF) before treatment and at 2, 4, 8, and 16 weeks after treatment.
Among the 30 patients, one participant in group B dropped out; therefore, a total of 29 patients completed this study and were successfully injected. After the injection, the VAS, SDQ, range of flexion and external rotation, and ISF improved in all groups compared with the preinjection status, regardless of treatment or time point. In the comparison between groups, the SDQ and ISF showed significantly greater improvements in groups B and C than in group A.
The therapeutic efficacy of combined low-dose corticosteroid and hyaluronidase is superior to that of low-dose corticosteroid and equivalent to that of high-dose corticosteroid in early AC.
本研究旨在比较低剂量类固醇、高剂量类固醇以及低剂量类固醇联合透明质酸酶在肩关节粘连性关节囊炎(AC)关节内注射治疗中的疗效。
将30例处于初始阶段的原发性AC患者随机分为三组,分别接受超声引导下关节内注射20mg曲安奈德(A组,n = 10)、40mg曲安奈德(B组,n = 10)以及20mg曲安奈德联合透明质酸酶(C组,n = 10)。观察指标包括视觉模拟评分法(VAS)、肩关节功能障碍问卷(SDQ)、外展和外旋活动范围,以及治疗前和治疗后2、4、8和16周时的鞘内积液(ISF)。
30例患者中,B组有1名参与者退出;因此,共有29例患者完成本研究并成功注射。注射后,与注射前状态相比,所有组的VAS、SDQ、屈曲和外旋范围以及ISF均有所改善,与治疗方法和时间点无关。组间比较中,B组和C组的SDQ和ISF改善程度明显大于A组。
在早期AC中,低剂量皮质类固醇联合透明质酸酶的治疗效果优于低剂量皮质类固醇,且与高剂量皮质类固醇相当。